Gentex (GNTX) Q4 2023 earnings summary

Executive summary

• Q4 sales reached a record $589.1m, up 19% YoY; FY2023 sales hit a record $2.30b, up 20% YoY.

• FY2023 revenue and profitability gains reflected higher product shipments, pricing actions, cost recoveries, and improved overhead leverage.

Financial highlights

• Q4 2023 gross margin was 34.5%, up 330 bps YoY; operating income rose 41% to $132.8m, and net income rose 36% to $116.9m.

• Q4 diluted EPS was $0.50, up 35% YoY; revenue included ~ $5m in one-time cost recoveries.

• FY2023 gross margin was 33.2%, up 140 bps YoY; operating income increased 34% to $495.7m and net income increased 34% to $428.4m.

• FY2023 diluted EPS was $1.84, up 35% YoY; operating expenses rose 11% to $266.9m.

Outlook and guidance

• 2024 revenue guidance: $2.45b–$2.55b; gross margin 34%–35%; operating expenses $295m–$305m; tax rate 16%–18%; capex $225m–$250m; D&A $95m–$105m.

• 2025 revenue is forecast at $2.65b–$2.75b, based on vehicle production forecasts and estimates for aerospace, medical, and fire protection products.

• Targeting 35%–36% gross margin by end-2024, through bill-of-material reductions, throughput gains, and lower overtime and scrap costs.

• R&D expense is expected to remain elevated throughout 2024 as product launches and innovation accelerate.